Endothelial cell injury in cardiovascular surgery: Atherosclerosis

Annals of Thoracic Surgery

Volumn 63, Issue 3, 1997, Pages 885-894

  Boyle Jr , Edward M ^a   Lille, Sean T ^a   Allaire, Eric ^a   Clowes, Alexander W ^a   Verrier, Edward D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR SURGERY; CELL DAMAGE; ENDOTHELIUM CELL; PRIORITY JOURNAL; REVIEW;

EID: 0342327371     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)00057-X     Document Type: Article

References (81)

1. Wissler RW, Hiltscher L, Oinuma T, PDAY Research Group. The lesions of atherosclerosis in the young. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:475-89.
2. Stary HC. The histological classification of atherosclerotic lesions in human coronary arteries. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:463-74.
3. Stary HC. Type I (initial) and type II (fatty streak lesions: minimal atherosclerotic lesions. In: Stary HC, ed. The evolution of human atherosclerotic lesions. West Point: Merck and Co, 1993:16-32.
4. Falk E, Shah PK, Fuster V. Pathogenesis of plaque distruption. In: Fuster V, Ross R, Topol EJ, eds. Artherosclerotic and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:491-507.
5. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in the 1990's: scope, concepts, potentials and perspectives. Circulation 1993;87:705-19.
6. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-91.
7. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985;121:394-403.
8. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A 1986;83: 4533-7.
9. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
10. Rollins BJ, Yoshimura T, Leonard EJ, et al. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136: 1229-33.
11. Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990;87:5134-8.
12. Rosenfeld M, Yla-Herttuala S, Lipton B, et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 1992;140: 291-300.
13. Clinton S, Underwood R, Hayes L, et al. Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140:301-16.
14. Matstumoto A, Naito M, Itakura H, et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci USA 1990;87:9133-7.
15. Shimokado K, Raines EW, Madtes DK, et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985;53:277-86.
16. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell 1988;53:285-93.
17. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type B transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-4.
18. Raines EW, Dover SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989;243:393-6.
19. Gay CG, Winkles JA. Interleukin-1 regulates heparin-binding growth factor 2 gene expression in vascular smooth mucle cells. Proc Natl Acad Sci U S A 1991;88:296-300.
20. Galis ZS, Sukhova GK, Kranzhofer R, et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1994;92:402-6.
21. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991;87:87-90.
22. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
23. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
24. Billingham ME. Pathology and etiology of chronic rejection of the heart. Clin Transplant 1994;8(3 Pt 2):289-92.
25. Hansson GK, Libby P. The role of the lymphocyte. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:557-68.
26. Badimon L, Badimon JJ. Interaction of platelet activation and coagulation. In: Fuster V, Ross R, Topol EJ, eds. Artherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:639-56.
27. Moore S, Freidman RJ, Singal DP, et al. Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb Haemost 1976;35:70-81.
28. Fuster V, Bgowie EJW, Lewis JC, et al. Resistance to atherosclerosis in pigs with Von-Willebrand's disease. Spontaneous and high-cholesterol diet-induced arteriosclerosis. J Clin Invest 1978;61:722-30.
29. Velican D, Velican C. Intimal thickening in developing coronary arteries and its relevance to atherosclerotic involvement. Atherosclerosis 1976;23:345-55.
30. Corson MA, Berk BC. Growth factors and the vessel wall. Heart Dis Stroke 1993;2(2):166-70.
31. Ross R, Glomset JA. Atherosclerosis and arterial smooth muscle cell. Science 1973;180:1332-9.
32. Wright TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:421-40.
33. Luscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993;44:395-418.
34. Luscher TF. The endothelium and cardiovascular disease - a complex relation. N Engl J Med 1994;330:1081-3.
35. Chobanian AV. 1989 Corocoran lecture: adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension 1990;15:666-74.
36. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
37. Dzau VJ, Anggard EE, Botting RM. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 1988; 62:30G-5G.
38. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscles by acetylcholine. Nature 1980;299:373-6.
39. Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992;20:253-63.
40. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle, and accelerated death. Diabetes 1985;34:621-7.
41. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-6.
42. Broze G. Endothelial injury, coagulation, and atherosclerosis. Coronary Artery Dis 1991;2:131-40.
43. Davie EW, Fumikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30:10363-70.
44. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol 1992;29:170-6.
45. Noll G, Luscher TF. Influence of lipoproteins on endothelial function. Thromb Res 1994;74:S45-54.
46. Shapiro S, Weinblatt E, Frank CW, Sager RV. Incidence of coronary heart disease in a population insured for medical care (HIP): myocardial infarction, angina pectoris, and possible myocardial infarction. Am J Public Health 1969;59:1-4.
47. Strong JP, Richards MC. Cigarette smoking and and atherosclerosis in autopsied men. Atherosclerosis 1976;23:451-76.
48. Stafford RS, Becker CG. Cigarette smoking and atherosclerosis. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:303-25.
49. Hladovec J. Endothelial injury by nicotine and its prevention. Experientia 1978;34:1585-6.
50. Zimmerman M, McGeachie JK. The effects of nicotine on aortic endothelial cell turnover and ultrastructure. Adv Exp Med Biol 1990;273:79-88.
51. Booyse FM, Osikowicz G, Quarfoot AJ. Effects of chronic oral consumption of nicotine on the rabbit aortic endothelium. Am J Pathol 1981;102:229-38.
52. Boutet M, Bazin M, Turcotte H, Lagace R. Effects of cigarette smoke on rat thoracic aorta. Artery 1980;7:56-72.
53. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats. Arterioscler Thromb 1992;12:1305-12.
54. Ernst E. Fibrinogen - an independent cardiovascular risk factor. J Intern Med 1990;227:365-72.
55. Powell JT. Smoking, nitric oxide and the endothelium. Br J Surg 1994;81:785-7.
56. Hunt SC, Hopkins PN, Williams RR. Genetics and mechanisms. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:209-35.
57. Gotlieb AI, Langille BL. The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:595-606.
58. Ku DN, Giddens DP, Zarins CK Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985;5:293-302.
59. Geiger RV, Berk BC, Alexander RW, Nerem RM. Flow-induced calcium transients in single endothelial cells: spatial and temporal analysis. Am J Physiol 1992;262(6 Pt 1): C1411-7.
60. Helmlinger G, Berk BC, Nerem RM. Calcium responses of endothelial cell monolayers subjected to pulsatile and steady laminar flow differ. Am J Physiol 1995;269(2 Pt 1): C367-75.
61. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB 1989;3:2007-18.
62. Bhagyalakshmi A, Frangos JA. Mechanism of shear-induced prostacyclin production in endothelial cells. Biochem Biophys Res Commun 1989;264:31-7.
63. Kuchan MJ, Frangos JA. Shear stress regulated endothelin-1 release via protein kinase C and cGMP in culture endothelial cells. Am J Physiol 1993;264:H150-6.
64. Hsieh HJ, Li NQ, Frangos JA. Pulsatile non-distended steady flow induces c-fos expression in human endothelial cells. J Cell Physiol 1993;154:143-51.
65. Langille BL, O'Donnell F. Reductions of arterial diameter produced by chronic diseases in blood flow are endothelium dependent. Science 1986;231:405-7.
66. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF, Gimbrone MA. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A 1993;90:4591-5.
67. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress [published erratum appears in Arterioscler Thromb Vase Biol 1995;15:429]. Atheroscler Thromb Vase Biol 1995;15:2-10.
68. Da Gamma AD, Sarmento C, Vieira T, do Carmo GX. The use of arterial allografts for vascular reconstruction in patients receiving immunosuppression for organ transplantation. J Vasc Surg 1994;20:271-8.
69. Hosenpud JD, Novik RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report. J Heart Lung Transplant 1994; 13:561-70.
70. Johnson DE, Alderman EL, Schroder JS, et al. Transplantation coronary artery disease: histopatholgic correlations with angiographic morphology. J Am Coll Cardiol 1991;17: 449-50.
71. Gao SZ, Hunt SA, Schroeder JS. Accelerated graft coronary artery disease. In: Shumway SJ, Shumway NE, eds. Thoracic transplantation. Cambridge: Blackwell Science, 1995:273-89.
72. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994; 19:446-56.
73. Adams DH, Russel ME, Hancock W, Sayegh MH, Wyner LR, Karnovsky MJ. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunol Rev 1993;134:5-19.
74. Pober JS, Orosx CG, Rose ML, Savage COS. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996;61:343-9.
75. Murray AG, Libby P, Poper JS. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogenic CD4+ T cell proliferation in vitro. J Immunol 1995;154: 151-61.
76. Solomon RN, Huges CCW, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-assocated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. J Pathol 1991;138:791-8.
77. Gohra H, McDonald TO, Verrier ED, Aziz S. Endothelial loss and regeneration in a model of transplant arteriosclerosis. Transplantation 1995;60:96-102.
78. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414-24.
79. Tanaka H, Swanson SJ, Sukhova G, Schoen FJ, Libby P. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 1995; 147:617-26.
80. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995;92:205-11.
81. Waldman WJ, Adams PW, Orosz CG, Sedmak DD. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992;54: 887-96.